Early research (Phase 1)Study completedNCT02473224
What this trial is testing
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Who this might be right for
Gastroenteritis Norovirus
National Institute of Allergy and Infectious Diseases (NIAID) 44